Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00136604
Status:
COMPLETED
Last Update Posted:
2020-02-20
First Post:
2005-08-26
Brief Title:
Response to GSK Biologicals Tritanrix-HepBHib-MenAC Vacc 4th Dose at 15-24m Mencevax ACWY at 24-30m
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Whole Cell Pertussis |
| Haemophilus Influenzae Type b |
| Hepatitis B |
| Diphtheria |
| Tetanus |
| Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin |